Tg Therapeutics (TGTX) EBIT (2011 - 2026)
Tg Therapeutics (TGTX) reported EBIT of $21.67 million for Q2 2026, down 37.8% from $34.84 million a year earlier and down 37.7% from the prior quarter.
Powered by 
Analysis
Tg Therapeutics (TGTX) EBIT (2011 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Tg Therapeutics' EBIT came in at $136.33 million, up 58.8% year-over-year; for FY2025, it was $123.32 million, up 194.1% from FY2024.
- By year, EBIT came in at $41.93 million in FY2024 (+103.2%), $20.63 million in FY2023, -$218.32 million in FY2022 and -$344.77 million in FY2021.
- The Q2 2026 figure ranks as the lowest quarterly EBIT since Q1 2025.
- Year over year, EBIT gained in four of the last six quarters, with growth averaging 112.8%.
- Per Business Quant data, the three quarters before Q2 2026 came in at $34.8 million (Q1 2026), $50.49 million (Q4 2025) and $29.37 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,167.12 Bn | 1,135.70 Bn | 19.71 Bn | 11.75 Bn |
| 2 | Johnson & Johnson | 647.48 Bn | 567.35 Bn | 17.30 Bn | 6.18 Bn |
| 3 | AbbVie | 502.73 Bn | 475.84 Bn | 12.70 Bn | 6.43 Bn |
| 4 | Merck | 363.86 Bn | 318.23 Bn | 12.21 Bn | -584.00 Mn |
| 5 | Novartis Ag | 303.31 Bn | 267.30 Bn | 11.24 Bn | 4.75 Bn |
| 6 | Astrazeneca | 269.08 Bn | 242.77 Bn | 12.86 Bn | 3.16 Bn |
| 7 | Amgen | 242.07 Bn | 197.46 Bn | 7.24 Bn | 3.51 Bn |
| 8 | Gilead Sciences | 194.93 Bn | 169.12 Bn | 6.22 Bn | -10.39 Bn |
| 9 | Pfizer | 172.42 Bn | 119.07 Bn | 10.94 Bn | 4.27 Bn |
| 10 | Tg Therapeutics | 7.50 Bn | 6.89 Bn | 199.14 Mn | 21.67 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 21.67 Mn |
| Mar 31, 2026 | 34.80 Mn |
| Dec 31, 2025 | 50.49 Mn |
| Sep 30, 2025 | 29.37 Mn |
| Jun 30, 2025 | 34.84 Mn |
| Mar 31, 2025 | 8.62 Mn |
| Dec 31, 2024 | 29.95 Mn |
| Sep 30, 2024 | 12.43 Mn |
| Jun 30, 2024 | 8.82 Mn |
| Mar 31, 2024 | -9.27 Mn |
| Dec 31, 2023 | -12.49 Mn |
| Sep 30, 2023 | 114.78 Mn |
| Jun 30, 2023 | -44.67 Mn |
| Mar 31, 2023 | -36.99 Mn |
| Dec 31, 2022 | -77.54 Mn |
| Sep 30, 2022 | -34.96 Mn |
| Jun 30, 2022 | -38.94 Mn |
| Mar 31, 2022 | -66.87 Mn |
| Dec 31, 2021 | -92.95 Mn |
| Sep 30, 2021 | -85.13 Mn |
API Access
Tg Therapeutics EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=TGTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "TGTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=TGTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();